Company news

OPKO Health, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

OPKO Health to Report Second Quarter 2020 Financial Results on July 30, 2020

July 26, 2020

OPKO Health's BioReference Laboratories Awarded Commercial Surge Capacity Testing for COVID-19 Emergency Response Contract by Centers for Disease Control and Prevention (CDC)

July 19, 2020

OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for National Basketball Association Players and Employees

July 12, 2020

Major League Soccer Chooses OPKO Health's BioReference Laboratories to Provide COVID-19 Testing for Players and Employees

July 8, 2020

OPKO Health Announces Positive Top-Line Results of Phase 3 Efficacy and Safety Study of Somatrogon for the Treatment of Japanese Children with Growth Hormone Deficiency

June 8, 2020

FDA Authorizes OPKO Health Clinical Trial Evaluating RAYALDEE in COVID-19 Patients

May 31, 2020

OPKO Health to Present at the Jefferies Virtual Healthcare Conference

May 26, 2020

OPKO Health Reports 2020 First Quarter Business Highlights and Financial Results

May 5, 2020

OPKO Health to Report First Quarter 2020 Financial Results on May 6, 2020

April 29, 2020

Somatrogon Phase 3 Pediatric Trial Results will be presented on June 8 at ENDO Online 2020

April 21, 2020

OPKO Health Reports Interim Results for Two Ongoing RAYALDEE Studies

March 24, 2020

OPKO Health Reports 2019 Fourth Quarter Business Highlights and Financial Results

February 25, 2020

OPKO Health to Report Fourth Quarter 2019 Financial Results on February 26, 2020

February 19, 2020

OPKO Health to Present at the 38th Annual J.P. Morgan Healthcare Conference

December 18, 2019

OPKO Health to Participate in the 31st Annual Piper Jaffray Healthcare Conference

November 25, 2019

Novitas Issues Final Local Coverage Determination for the 4Kscore® Test

November 14, 2019

OPKO Health Reports 2019 Third Quarter Business Highlights and Financial Results

November 4, 2019

OPKO Health to Report Third Quarter 2019 Financial Results on November 5, 2019

October 31, 2019

OPKO Health, Inc. Announces Pricing of its Offering of Common Stock

October 23, 2019

OPKO Health, Inc. Announces Proposed Offering of Common Stock

October 21, 2019

OPKO and Pfizer Announce Positive Phase 3 Top-Line Results for Somatrogon, an Investigational Long-Acting Human Growth Hormone to Treat Children with Growth Hormone Deficiency

October 20, 2019

BioReference Laboratories Recognized by Forbes as Best Large Employer of 2019

April 16, 2019

OPKO Reports Additional Oxyntomodulin, OPK-88003, Results From Phase 2 Diabetes and Obesity Trial

April 11, 2019

← Newer news releases

Calls

The 5 newest of 25 calls. Every call is listed under its year.

Decks

The 5 newest of 31 decks. Every deck is listed under its year.